Market cap
$3 Mln
Revenue (TTM)
$2 Mln
P/E Ratio
--
P/B Ratio
0.5
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 21.22 | 1,190.30 | 376.80 | 9.54 | 9.18 |
| EBIT | -15.19 | -232.16 | -121.70 | -22.44 | -211.61 |
| Net Profit | -14.53 | -267.84 | -195.69 | -140.25 | -216.70 |
| EPS | -2,342.78 | -2,297.77 | 6.93 | 24.71 | 13.88 |
| Book Value | -- | -- | 1,560.98 | -50.85 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -1,377.65 | -- | -745.03 | -2,054.19 | -- |
| Net Margin
| -- | -- | -1,003.19 | -- | -- |
| Return on equity
| -168.50 | -- | -130.74 | -91.85 | -184.96 |
| Return on Capital
| -148.87 | -- | -- | -68.86 | -174.43 |
| Return on Assets
| -114.36 | -- | -91.80 | -51.60 | -142.01 |
| Debt to Equity (x)
| -- | -- | 0.62 | 0.38 | -- |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
--
|
-68.86
|
-174.43
|
-203.33
|
-111.31
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-130.74
Lower than Peers by 133.92
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
-130.74
|
-91.85
|
-184.96
|
-228.68
|
-119.47
|
|
Peer Median
|
3.18
|
--
|
--
|
--
|
--
|
ROA
-91.80
Lower than Peers by 94.27
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
-91.80
|
-51.60
|
-142.01
|
-149.46
|
-96.56
|
|
Peer Median
|
2.46
|
--
|
--
|
--
|
--
|
EBIT Margin
-745.03
Lower than Peers by 759.17
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
-745.03
|
-2,054.19
|
--
|
-701.11
|
-548.80
|
|
Peer Median
|
14.14
|
--
|
--
|
--
|
--
|
Net Margin
-1,003.19
Lower than Peers by 1,013.38
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
-1,003.19
|
-2,324.08
|
--
|
-701.02
|
-548.70
|
|
Peer Median
|
10.20
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
Lower than Peers by 0.00
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Revenue Growth
376.80
Higher than Peers by 342.94
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
376.80
|
--
|
-1.00
|
-0.36
|
0.46
|
|
Peer Median
|
33.86
|
--
|
--
|
--
|
--
|
EBIT Growth
-121.70
Lower than Peers by 333.26
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
-121.70
|
-77.69
|
46.44
|
18.35
|
-79.27
|
|
Peer Median
|
211.56
|
--
|
--
|
--
|
--
|
Net Profit Growth
-195.69
Lower than Peers by 506.99
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
-195.69
|
-56.99
|
31.40
|
18.34
|
-18.86
|
|
Peer Median
|
311.29
|
--
|
--
|
--
|
--
|
EPS Growth
6.93
--
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
6.93
|
-2.94
|
0.89
|
0.95
|
-0.19
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Book Value Growth
2,001.23
Higher than Peers by 1,973.49
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
2,001.23
|
--
|
--
|
--
|
--
|
|
Peer Median
|
27.74
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.62
Higher than Peers by 0.62
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
0.62
|
0.38
|
--
|
0.10
|
0.15
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.04
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
0.04
|
0.03
|
--
|
0.05
|
0.04
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.11
Lower than Peers by 1.70
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
1.11
|
20.13
|
9.70
|
3.32
|
2.83
|
|
Peer Median
|
2.81
|
--
|
--
|
--
|
--
|
Quick Ratio
0.86
Lower than Peers by 1.73
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
0.86
|
--
|
8.53
|
2.78
|
2.37
|
|
Peer Median
|
2.60
|
--
|
--
|
--
|
--
|
Interest Coverage
-11.95
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
-11.95
|
-53.75
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
76.95
Higher than Peers by 61.56
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
76.95
|
0.26
|
--
|
14.80
|
5.82
|
|
Peer Median
|
15.39
|
--
|
--
|
--
|
--
|
Asset Turnover
0.09
Lower than Peers by 0.12
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
0.09
|
0.02
|
--
|
0.21
|
0.18
|
|
Peer Median
|
0.21
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
--
|
33.47
|
--
|
43.64
|
19.75
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
--
|
332.90
|
557.73
|
332.59
|
153.12
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
--
|
202.97
|
434.77
|
418.25
|
250.29
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
--
|
163.39
|
--
|
-42.03
|
-77.43
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
--
|
-0.04
|
-0.58
|
-0.32
|
-0.61
|
|
Peer Median
|
35.29
|
--
|
--
|
--
|
--
|
Price / Book Value
0.52
Lower than Peers by 0.67
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
0.52
|
0.02
|
1.29
|
0.74
|
1.71
|
|
Peer Median
|
1.19
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
--
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
--
|
0.75
|
-0.31
|
0.05
|
-0.32
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
3
Lower than Peers by 471
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Valion Bio Inc (VBIO)
|
3
|
--
|
--
|
--
|
--
|
|
Peer Median
|
474
|
--
|
--
|
--
|
--
|